Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Conjugation of Meningococcal Lipooligosaccharides Through Their Non-Reducing Terminus Results in Improved Induction a Protective Immune Response.

Mieszała M, Jennings HJ, Drab M, Gamian A.

Arch Immunol Ther Exp (Warsz). 2019 Aug;67(4):237-248. doi: 10.1007/s00005-019-00542-9. Epub 2019 Apr 27.

2.

Exploring the experiences of parents caring for infants with developmental dysplasia of the hip attending a dedicated clinic.

Jennings HJ, Gooney M, O'Beirne J, Sheahan L.

Int J Orthop Trauma Nurs. 2017 May;25:48-53. doi: 10.1016/j.ijotn.2016.10.004. Epub 2016 Nov 5. Review.

PMID:
27979662
3.

The antigen-binding site of an N-propionylated polysialic acid-specific antibody protective against group B meningococci is consistent with extended epitopes.

Johal AR, Jarrell HC, Letts JA, Khieu NH, Landry RC, Jachymek W, Yang Q, Jennings HJ, Brisson JR, Evans SV.

Glycobiology. 2013 Aug;23(8):946-54. doi: 10.1093/glycob/cwt031. Epub 2013 May 22.

PMID:
23704298
4.

Sialyltransferase inhibitors: consideration of molecular shape and charge/hydrophobic interactions.

Kumar R, Nasi R, Bhasin M, Huan Khieu N, Hsieh M, Gilbert M, Jarrell H, Zou W, Jennings HJ.

Carbohydr Res. 2013 Aug 30;378:45-55. doi: 10.1016/j.carres.2012.12.017. Epub 2013 Jan 10.

PMID:
23374752
5.

Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.

Pincus SH, Moran E, Maresh G, Jennings HJ, Pritchard DG, Egan ML, Blixt O.

Vaccine. 2012 Jul 6;30(32):4849-58. doi: 10.1016/j.vaccine.2012.05.006. Epub 2012 May 23.

6.

Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.

Krug LM, Ragupathi G, Hood C, George C, Hong F, Shen R, Abrey L, Jennings HJ, Kris MG, Livingston PO.

Cancer Immunol Immunother. 2012 Jan;61(1):9-18. doi: 10.1007/s00262-011-1083-6. Epub 2011 Aug 3.

7.

Polysialic acid bioengineering of cancer and neuronal cells by N-acyl sialic acid precursor treatment.

Pon RA, Zou W, Jennings HJ.

Adv Exp Med Biol. 2011;705:679-88. doi: 10.1007/978-1-4419-7877-6_36. No abstract available.

PMID:
21618136
8.

Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.

Guttormsen HK, Paoletti LC, Mansfield KG, Jachymek W, Jennings HJ, Kasper DL.

Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5903-8. doi: 10.1073/pnas.0710799105. Epub 2008 Mar 31.

9.

Polysialic acid bioengineering of neuronal cells by N-acyl sialic acid precursor treatment.

Pon RA, Biggs NJ, Jennings HJ.

Glycobiology. 2007 Mar;17(3):249-60. Epub 2006 Dec 15.

PMID:
17172262
10.

Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae.

Kadirvelraj R, Gonzalez-Outeiriño J, Foley BL, Beckham ML, Jennings HJ, Foote S, Ford MG, Woods RJ.

Proc Natl Acad Sci U S A. 2006 May 23;103(21):8149-54. Epub 2006 May 16.

11.

Bioengineering of surface GD3 ganglioside for immunotargeting human melanoma cells.

Zou W, Borrelli S, Gilbert M, Liu T, Pon RA, Jennings HJ.

J Biol Chem. 2004 Jun 11;279(24):25390-9. Epub 2004 Mar 26.

12.

Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.

Krug LM, Ragupathi G, Ng KK, Hood C, Jennings HJ, Guo Z, Kris MG, Miller V, Pizzo B, Tyson L, Baez V, Livingston PO.

Clin Cancer Res. 2004 Feb 1;10(3):916-23.

13.

Characterization of polysaccharide conformational epitopes by surface plasmon resonance.

MacKenzie CR, Jennings HJ.

Methods Enzymol. 2003;363:340-54.

PMID:
14579587
14.

Epimerization of 2'-carbonylalkyl-C-glycosides via enolation, beta-elimination and intramolecular cycloaddition.

Wang Z, Shao H, Lacroix E, Wu SH, Jennings HJ, Zou W.

J Org Chem. 2003 Oct 17;68(21):8097-105.

PMID:
14535789
16.

The conformational epitope of type III group B Streptococcus capsular polysaccharide.

Zou W, Jennings HJ.

Adv Exp Med Biol. 2001;491:473-84.

PMID:
14533816
17.

NMR studies of carbohydrates and carbohydrate-mimetic peptides recognized by an anti-group B Streptococcus antibody.

Johnson MA, Jaseja M, Zou W, Jennings HJ, Copie V, Pinto BM, Pincus SH.

J Biol Chem. 2003 Jul 4;278(27):24740-52. Epub 2003 Apr 16.

19.

Discovery of an alpha 2,9-PolyNeu5Ac glycoprotein in C-1300 murine neuroblastoma (clone NB41A3).

Inoue S, Poongodi GL, Suresh N, Jennings HJ, Inoue Y.

J Biol Chem. 2003 Mar 7;278(10):8541-6. Epub 2002 Dec 18.

20.

Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.

Brigtsen AK, Kasper DL, Baker CJ, Jennings HJ, Guttormsen HK.

J Infect Dis. 2002 May 1;185(9):1277-84. Epub 2002 Apr 3.

PMID:
12001045
21.

Novel zinc (II)-mediated epimerization of 2'-carbonylalkyl-alpha-C-glycopyranosides to their beta-anomers.

Shao H, Wang Z, Lacroix E, Wu SH, Jennings HJ, Zou W.

J Am Chem Soc. 2002 Mar 13;124(10):2130-1.

PMID:
11878963
22.

Multifunctionalized alpha,beta-cyclopentenones from C-2 and C-4-ulopyranosyl compounds: a stereospecific rearrangement initiated by base.

Zou W, Wang Z, Lacroix E, Wu SH, Jennings HJ.

Carbohydr Res. 2001 Aug 30;334(3):223-31.

PMID:
11513829
23.

Construction of multivalent sialyl Le(x) from the type Ia group B Streptococcus capsular polysaccharide.

Zou W, Li J, Larocque S, Jennings HJ.

Carbohydr Res. 2001 Jun 4;332(3):249-55.

PMID:
11376605
24.

Immunostimulant oxidized beta-glucan conjugates.

Cross GG, Jennings HJ, Whitfield DM, Penney CL, Zacharie B, Gagnon L.

Int Immunopharmacol. 2001 Mar;1(3):539-50.

PMID:
11367537
25.

Biochemical engineering of surface alpha 2-8 polysialic acid for immunotargeting tumor cells.

Liu T, Guo Z, Yang Q, Sad S, Jennings HJ.

J Biol Chem. 2000 Oct 20;275(42):32832-6.

26.
27.

T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria.

Tzianabos AO, Finberg RW, Wang Y, Chan M, Onderdonk AB, Jennings HJ, Kasper DL.

J Biol Chem. 2000 Mar 10;275(10):6733-40.

29.

Synthesis of a disialylated hexasaccharide of type VIII group B Streptococcus capsular polysaccharide.

Eichler E, Jennings HJ, Gilbert M, Whitfield DM.

Carbohydr Res. 1999 Jun 30;319(1-4):1-16.

PMID:
10520252
30.

Synthesis and NMR assignments of galactosylgloboside and its beta-D-GalNAc-(1-->4)-alpha-D-Gal-linked positional isomer in a conjugatable form.

Zou W, Brisson JR, Larocque S, Gardner RL, Jennings HJ.

Carbohydr Res. 1999 Feb 28;315(3-4):251-61.

PMID:
10399298
31.

Conformational epitope of the type III group B Streptococcus capsular polysaccharide.

Zou W, Mackenzie R, Thérien L, Hirama T, Yang Q, Gidney MA, Jennings HJ.

J Immunol. 1999 Jul 15;163(2):820-5.

32.

Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.

Rubinstein LJ, García-Ojeda PA, Michon F, Jennings HJ, Stein KE.

Infect Immun. 1998 Nov;66(11):5450-6.

33.

Crystallization and preliminary X-ray diffraction analysis of antigen-binding fragments which are specific for antigenic conformations of sialic acid homopolymers.

Patenaude SI, Vijay SM, Yang QL, Jennings HJ, Evans SV.

Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):1005-7.

PMID:
9757121
35.
36.

Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen.

Pincus SH, Smith MJ, Jennings HJ, Burritt JB, Glee PM.

J Immunol. 1998 Jan 1;160(1):293-8.

37.
38.

NMR and molecular dynamics studies of the conformational epitope of the type III group B Streptococcus capsular polysaccharide and derivatives.

Brisson JR, Uhrinova S, Woods RJ, van der Zwan M, Jarrell HC, Paoletti LC, Kasper DL, Jennings HJ.

Biochemistry. 1997 Mar 18;36(11):3278-92.

PMID:
9116006
39.

Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes.

Kogan G, Uhrín D, Brisson JR, Jennings HJ.

Carbohydr Res. 1997 Mar 5;298(3):191-9.

PMID:
9090813
40.

The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.

Laferrière CA, Sood RK, de Muys JM, Michon F, Jennings HJ.

Vaccine. 1997 Feb;15(2):179-86.

PMID:
9066036
42.

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.

Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ.

J Clin Invest. 1996 Nov 15;98(10):2308-14.

43.

Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide.

Kogan G, Uhrín D, Brisson JR, Paoletti LC, Blodgett AE, Kasper DL, Jennings HJ.

J Biol Chem. 1996 Apr 12;271(15):8786-90.

44.

Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy.

Kogan G, Brisson JR, Kasper DL, von Hunolstein C, Orefici G, Jennings HJ.

Carbohydr Res. 1995 Nov 7;277(1):1-9.

PMID:
8548782
45.

Structural elucidation of the capsular polysaccharide of Bacteroides fragilis strain 23745M1.

Pavliak V, Uhrín D, Brisson JR, Tzianabos AO, Kasper DL, Jennings HJ.

Carbohydr Res. 1995 Oct 2;275(2):333-41.

PMID:
8529227
46.

Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid.

Evans SV, Sigurskjold BW, Jennings HJ, Brisson JR, To R, Tse WC, Altman E, Frosch M, Weisgerber C, Kratzin HD, et al.

Biochemistry. 1995 May 23;34(20):6737-44.

PMID:
7538787
48.

1D analogs of 3D NOESY-TOCSY and 4D TOCSY-NOESY-TOCSY. Application to polysaccharides.

Uhrín D, Brisson JR, Kogan G, Jennings HJ.

J Magn Reson B. 1994 Jul;104(3):289-93. No abstract available.

PMID:
8069487
49.

Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine.

Marques MB, Kasper DL, Shroff A, Michon F, Jennings HJ, Wessels MR.

Infect Immun. 1994 May;62(5):1593-9.

50.

Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine.

Wessels MR, Paoletti LC, Rodewald AK, Michon F, DiFabio J, Jennings HJ, Kasper DL.

Infect Immun. 1993 Nov;61(11):4760-6.

Supplemental Content

Loading ...
Support Center